Virax Biolabs Group Limited (NASDAQ:VRAX) shares are trending on Tuesday.
VRAX shares rose 17.36% to $0.28 in after-hours trading on Monday.
The jump in the late trading session follows an intraday gain of 53.09%, closing the stock at $0.24, according to Benzinga Pro data.
Armistice Capital Takes 4.99% Stake in VRAX
On May 15, Armistice Capital, LLC, a New York-based hedge fund, filed a Securities and Exchange Commission disclosure revealing a 4.99% beneficial ownership stake of over 1 million ordinary shares. The fund was founded in 2012 by Managing Member Steven Boyd, who signed the filing.
